The cyclin-dependent kinase inhibitor (CDKI) p21CIP1 regulates leukemic cell differentiation and apoptosis induced by low concentrations of 1-β-D-arabinofuranosylcytosine (ara-C).

被引：0
|
作者：
Wang, ZL
Fisher, P
Dent, P
Grant, S
机构：
[1] Virginia Commonwealth Univ, Med Coll Virginia, Dept Med, Richmond, VA 23298 USA
[2] Virginia Commonwealth Univ, Med Coll Virginia, Dept Radiat Oncol, Richmond, VA 23298 USA
[3] Columbia Univ, Coll Phys & Surg, New York, NY USA
来源：
CLINICAL CANCER RESEARCH | 1999年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
436
引用
收藏
页码：3817S / 3817S
页数：1
相关论文
共 50 条
  • [1] Evidence of a functional role for the cyclin-dependent kinase inhibitor p21CIP1 in leukemic cell (U937) differentiation induced by low concentrations of 1-β-D-arabinofuranosylcytosine
    Wang, ZL
    Wang, SJ
    Fisher, PB
    Dent, P
    Grant, S
    DIFFERENTIATION, 2000, 66 (01) : 1 - 13
  • [2] Apoptosis, cell proliferation and modulation of cyclin-dependent kinase inhibitor p21cip1 in vascular remodelling during vein arterialization in the rat
    Borin, Thaiz Ferraz
    Miyakawa, Ayumi Aurea
    Cardoso, Leandro
    Borges, Luciano de Figueiredo
    Goncalves, Giovana Aparecida
    Krieger, Jose Eduardo
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2009, 90 (03) : 328 - 337
  • [3] Suppression of arthritis by forced expression of cyclin-dependent kinase inhibitor p21Cip1 gene into the joints
    Nonomura, Y
    Kohsaka, H
    Nasu, K
    Terada, Y
    Ikeda, M
    Miyasaka, N
    INTERNATIONAL IMMUNOLOGY, 2001, 13 (06) : 723 - 731
  • [4] Evaluation of the cyclin-dependent kinase inhibitor p21Cip1 in epithelial ovarian tumors of low malignant potential and adenocarcinomas
    Vassilopoulos, I
    Korkolopoulou, P
    Konstantinidou, AE
    Patsouris, E
    Eftichiadis, C
    Thymara, I
    Perdiki, M
    Pavlakis, K
    Agapitos, E
    Davaris, PS
    HISTOLOGY AND HISTOPATHOLOGY, 2003, 18 (03) : 761 - 770
  • [5] Mitotic p21Cip1/CDKN1A is regulated by cyclin-dependent kinase 1 phosphorylation
    Kreis, Nina-Naomi
    Friemel, Alexandra
    Zimmer, Brigitte
    Roth, Susanne
    Rieger, Michael A.
    Rolle, Udo
    Louwen, Frank
    Yuan, Juping
    ONCOTARGET, 2016, 7 (31) : 50215 - 50228
  • [6] The cyclin-dependent kinase inhibitor p21Cip1: Modes of action and role in the resistance to antitumour agents.
    Cayrol, C
    Ducommun, B
    EUROPEAN JOURNAL OF CELL BIOLOGY, 1997, 72 : 67 - 67
  • [7] The cyclin-dependent kinase inhibitors p27Kip1 and p21Cip1 are not essential in T cell anergy
    Verdoodt, B
    Blazek, T
    Rauch, P
    Schuler, G
    Steinkasserer, A
    Lutz, MB
    Funk, JO
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (11) : 3154 - 3163
  • [8] The p21Cip1/Waf1 cyclin-dependent kinase inhibitor is required for the activation of the FA-BRCA pathway
    Rego, Meghan A.
    Mauro, Maurizio
    Harney, Julie A.
    Shen, Mae
    Kolling, Frederick W.
    Howlett, Niall G.
    CANCER RESEARCH, 2010, 70
  • [9] Pivotal role of the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in apoptosis and autophagy
    Fujiwara, Keishi
    Daido, Shigeru
    Yamamoto, Akitsugu
    Kobayashi, Ryuji
    Yokoyama, Tomohisa
    Aoki, Hiroshi
    Iwado, Eiji
    Shinojima, Naoki
    Kondo, Yasuko
    Kondo, Seiji
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (01) : 388 - 397
  • [10] Multiple molecular effects of cyclin-dependent kinase inhibitor p21Cip1 gene induction for treatment of arthritis.
    Nonomura, Y
    Kohsaka, H
    Nagasaka, K
    Miyasaka, N
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S606 - S606
12345